About
Company
Latest News
Contact Us
History
Careers
Policies
Editorial Policies
Open Access Policy
Research and Publication Ethics
Peer-review Policies
Publication Fees
Advertising Policy
Journals
All Journals
Active Journals
Archived Journals
Services
Language Editing
Layout & Production
Graphic Abstracts
Video Abstracts
Submission System
Collaborations
Strategic Collaborators
Journal Membership
Conference Parterships
Insights
Latest Articles
Academic Talks
Interactive Webinars
Academic Support
Author Hub
Editor Hub
Reviewer Hub
Conference Organizer
Expert Lecture
Search
Log In
Home
Volumes
Volume7, Issue-1 (2024)
Volume
Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286a
Emerging role of MYB transcription factors in cancer drug resistance
HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugs
The therapeutic potential of circular RNA in triple-negative breast cancer
Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells
Dysregulation of calcium homeostasis in cancer and its role in chemoresistance
Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer model
Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancer
Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications
Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia
Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors
Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxel
Targeting T regulatory (T<sub>reg</sub>) cells in immunotherapy-resistant cancers
Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progression
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
editorial@cdrjournal.com
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/